DR. REDDY'S LABORATORIES-ADR (RDY)
US2561352038 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 215.452B 13.11% | 246.697B 14.50% | 280.111B 13.54% | 316.547B 13.01% | 342.987B 8.35% | 349.58B 1.92% | 366.255B 4.77% | 391.67B 6.94% | N/A | |
| EBITDA YoY % growth | 46.981B 3.23% | 65.4B 39.21% | 79.334B 21.31% | 88.902B 12.06% | 94.655B 6.47% | 80.422B -15.04% | 110.679B 37.62% | 126.632B 14.41% | 187.691B 48.22% | |
| EBIT YoY % growth | 35.329B 6.35% | 52.898B 49.73% | 64.634B 22.19% | 72.708B 12.49% | 76.18B 4.78% | 60.749B -20.26% | 94.998B 56.38% | 110.339B 16.15% | 179.7B 62.86% | |
| Operating Margin | 16.40% | 21.44% | 23.07% | 22.97% | 22.21% | 17.38% | 25.94% | 28.17% | N/A | |
| EPS YoY % growth | 142.47 23.56% | 271.24 90.38% | 334.84 23.45% | 70.07 -79.07% | 72.60 3.62% | 60.02 -17.33% | N/A | N/A | N/A |
All data in INR
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 18.30 -77.90% | 18.52 -76.37% | 17.66 5.75% | 19.31 28.30% |
| Revenue Q2Q % growth | 81.528B 12.66% | 81.65B 14.78% | 84.49B 9.78% | 89.482B 11.32% |
| EBITDA Q2Q % growth | 22.166B 12.91% | 22.313B -23.53% | N/A | N/A |
| EBIT Q2Q % growth | 18.253B 9.92% | 18.047B 24.65% | 19.433B 11.06% | 21.252B 19.94% |
All data in INR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 15.05 -96.62% | 17.32 | -2.27 | -13.10% |
| Q1 2025 Q2Q % growth | 16.70 -80.23% | 15.65 | 1.05 | 6.71% |
| Q4 2024 Q2Q % growth | 78.35 35.67% | 74.75 | 3.60 | 4.81% |
| Q3 2024 Q2Q % growth | 82.81 10.63% | 75.41 | 7.39 | 9.80% |
| Q2 2024 Q2Q % growth | 445.09 563.71% | 74.03 | 371.06 | 501.26% |
| Q1 2024 Q2Q % growth | 84.46 18.00% | 62.04 | 22.43 | 36.15% |
| Q4 2023 Q2Q % growth | 57.75 889.37% | 49.03 | 8.72 | 17.78% |
| Q3 2023 Q2Q % growth | 74.85 75.99% | 66.10 | 8.75 | 13.23% |
| Q2 2023 Q2Q % growth | 67.06 12.29% | 48.19 | 18.87 | 39.15% |
| Q1 2023 Q2Q % growth | 71.58 108.18% | 38.89 | 32.69 | 84.05% |
| Q4 2022 Q2Q % growth | 5.84 -82.49% | 40.49 | -34.66 | -85.59% |
| Q3 2022 Q2Q % growth | 42.53 3,469.75% | 44.92 | -2.39 | -5.31% |
| Q2 2022 Q2Q % growth | 59.72 30.15% | 41.11 | 18.61 | 45.28% |
| Q1 2022 Q2Q % growth | 34.38 -1.49% | 40.26 | -5.88 | -14.61% |
| Q4 2021 Q2Q % growth | 33.33 -27.71% | 39.80 | -6.47 | -16.25% |
| Q3 2021 Q2Q % growth | 1.19 103.46% | 44.05 | -42.86 | -97.30% |
| Q2 2021 Q2Q % growth | 45.89 -30.37% | 37.28 | 8.61 | 23.09% |
| Q1 2021 Q2Q % growth | 34.90 -12.65% | 31.01 | 3.90 | 12.57% |
| Q4 2020 Q2Q % growth | 46.11 76.03% | 32.83 | 13.28 | 40.44% |
| Q3 2020 Q2Q % growth | -34.41 -217.67% | 30.01 | -64.42 | -214.68% |
| Q2 2020 Q2Q % growth | 65.90 117.16% | 34.35 | 31.55 | 91.86% |
| Q1 2020 Q2Q % growth | 39.96 45.39% | 27.94 | 12.01 | 42.99% |
| Q4 2019 Q2Q % growth | 26.19 59.90% | 24.49 | 1.70 | 6.95% |
| Q3 2019 Q2Q % growth | 29.25 60.32% | 23.53 | 5.72 | 24.29% |
| Q2 2019 Q2Q % growth | 30.35 64.82% | 21.28 | 9.07 | 42.61% |
| Q1 2019 Q2Q % growth | 27.48 584.54% | 18.65 | 8.84 | 47.38% |
| Q4 2018 Q2Q % growth | 16.38 | 22.43 | -6.05 | -26.97% |
| Q3 2018 Q2Q % growth | 18.24 | 19.78 | -1.54 | -7.76% |
| Q2 2018 Q2Q % growth | 18.41 | 17.41 | 1.00 | 5.75% |
| Q1 2018 Q2Q % growth | 4.01 | 21.09 | -17.08 | -80.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 80.382B 16.45% | 78.202B | 2.18B | 2.79% |
| Q1 2025 Q2Q % growth | 76.961B 13.88% | 74.271B | 2.69B | 3.62% |
| Q4 2024 Q2Q % growth | 71.138B 12.65% | 72.58B | -1.442B | -1.99% |
| Q3 2024 Q2Q % growth | 72.368B 6.58% | 70.667B | 1.701B | 2.41% |
| Q2 2024 Q2Q % growth | 69.026B 9.01% | 69.536B | -510M | -0.73% |
| Q1 2024 Q2Q % growth | 67.579B 29.14% | 66.455B | 1.124B | 1.69% |
| Q4 2023 Q2Q % growth | 63.152B 15.35% | 61.607B | 1.545B | 2.51% |
| Q3 2023 Q2Q % growth | 67.898B 27.19% | 62.062B | 5.836B | 9.40% |
| Q2 2023 Q2Q % growth | 63.318B 9.42% | 58.494B | 4.824B | 8.25% |
| Q1 2023 Q2Q % growth | 52.329B 5.82% | 54.772B | -2.443B | -4.46% |
| Q4 2022 Q2Q % growth | 54.749B 14.82% | 52.723B | 2.026B | 3.84% |
| Q3 2022 Q2Q % growth | 53.383B 8.02% | 55.205B | -1.822B | -3.30% |
| Q2 2022 Q2Q % growth | 57.869B 17.84% | 52.999B | 4.87B | 9.19% |
| Q1 2022 Q2Q % growth | 49.451B 11.72% | 52.74B | -3.289B | -6.24% |
| Q4 2021 Q2Q % growth | 47.682B 7.18% | 49.377B | -1.695B | -3.43% |
| Q3 2021 Q2Q % growth | 49.419B 12.39% | 51.608B | -2.189B | -4.24% |
| Q2 2021 Q2Q % growth | 49.109B 2.04% | 47.456B | 1.653B | 3.48% |
| Q1 2021 Q2Q % growth | 44.265B 14.73% | 42.656B | 1.609B | 3.77% |
| Q4 2020 Q2Q % growth | 44.489B 10.41% | 43.094B | 1.395B | 3.24% |
| Q3 2020 Q2Q % growth | 43.971B 13.78% | 43.062B | 909M | 2.11% |
| Q2 2020 Q2Q % growth | 48.128B 26.07% | 43.273B | 4.855B | 11.22% |
| Q1 2020 Q2Q % growth | 38.582B 3.26% | 40.815B | -2.233B | -5.47% |
| Q4 2019 Q2Q % growth | 40.296B 13.39% | 39.669B | 627M | 1.58% |
| Q3 2019 Q2Q % growth | 38.646B 0.80% | 39.73B | -1.084B | -2.73% |
| Q2 2019 Q2Q % growth | 38.175B 7.24% | 38.745B | -570M | -1.47% |
| Q1 2019 Q2Q % growth | 37.365B 12.10% | 37.151B | 214M | 0.58% |
| Q4 2018 Q2Q % growth | 35.539B | 37.871B | -2.332B | -6.16% |
| Q3 2018 Q2Q % growth | 38.341B | 37.578B | 763M | 2.03% |
| Q2 2018 Q2Q % growth | 35.598B | 37.733B | -2.135B | -5.66% |
| Q1 2018 Q2Q % growth | 33.332B | 34.873B | -1.541B | -4.42% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -79.94% | -77.37% | -80.02% | -79.98% |
| Revenue | 0% | 6.16% | 0% | 0.53% |